References
- Brown MB, Traynor MJ, Martin GP, et al. Transdermal drug delivery systems: skin perturbation devices. Methods Mol Biol. 2008;437:119–139.
- Shende P, Patil A, Prabhakar B. Layer-by-layer technique for enhancing physicochemical properties of actives. J Drug Deliv Sci Technol. 2020;56:101519.
- Hy IMOT. Transdermal penetration enhancers: applications, limitations and potential. J Pharm Sci. 1999;88:955–958.
- Shende P, Sardesai M, Gaud RS. Micro to nanoneedles: a trend of modernized transepidermal drug delivery system. Artif Cells Nanomed Biotechnol. 2018;46(1):19–25.
- Guy RH, Hadgraft J, Bucks DA. Transdermal drug delivery and cutaneous metabolism. Xenobiotica. 1987;17(3):325–343.
- Patil A, Narvenker R, Prabhakar B, et al. Strategic consideration for effective chemotherapeutic transportation via transpapillary route in breast cancer. Int J Pharm. 2020;586:19:119563.
- Bariya SH, Gohel MC, Mehta TA, et al. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64(1):11–29.
- Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–1268.
- Shende P, Waghchaure M. Combined vaccines for prophylaxis of infectious conditions. Artif Cells Nanomed Biotechnol. 2019;47(1):695–704.
- Pawar S, Shende P. 22 Factorial design-based biocompatible microneedle arrays containing artemether co-loaded with lumefantrine nanoparticles for transepidermal delivery. Biomed Microdevices. 2020;22(1):1–15.
- G. Nava-Arzaluz M, Calderon-Lojero I, Quintanar-Guerrero D, et al. Microneedles as transdermal delivery systems: combination with other enhancing strategies. CDD. 2012;9(1):57–73.
- Smith EW, Maibach HI. Percutaneous penetration enhancers. 2nd ed. 2005. London: CRC Press.
- Shende P, Sahu P, Gaud R. A technology roadmap of smart biosensors from conventional glucose monitoring systems. Ther Deliv. 2017;8(6):411–423.
- Pawar S, Shende P. A comparative outlook on pharmacokinetics and antimalarial studies of artemether and lumefantrine-loaded microneedle patches and a dry suspension containing nanosponges. J Drug Deliv Sci Technol. 2020;60:102055.
- Finnin BC, Morgan TM. Transdermal penetration enhancers: applications, limitations and potential. J Pharm Sci. 1999;88:955–958.
- Escobar-Chavez JJ, Rodríguez Cruz IM, Dominguez-Delgado CL. Chemical and physical enhancers for transdermal drug delivery. Pharmacology. 2012;7:978–953.
- Mitragotri S, Anissimov YG, Bunge AL, et al. Mathematical models of skin permeability: an overview. Int J Pharm. 2011;418(1):115–129.
- Higuchi T. Physical–chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem. 1960;11:85.
- Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101–114.
- Ita KB, Popova IE. Influence of sonophoresis and chemical penetration enhancers on percutaneous transport of penbutolol sulfate. Pharm Dev Technol. 2016;21(8):990–995.
- Wang Y, Thakur R, Fan Q, et al. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm. 2005;60(2):179–191.
- Rizwan M, Aqil M, Talegaonkar S, et al. Enhanced transdermal drug delivery techniques: an extensive review of patents. Recent Pat Drug Deliv Formul. 2009;3(2):105–124.
- Chen H, Zhu H, Zheng J, et al. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release. 2009;139(1):63–72.
- Vemulapalli V, Yang Y, Friden PM, et al. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol. 2008;60(1):27–33.
- Park D, Park H, Seo J, et al. Sonophoresis in transdermal drug delivery. Ultrasonics. 2014;54(1):56–65.
- Oberli MA, Schoellhammer CM, Langer R, et al. Ultrasound-enhanced transdermal delivery: recent advances and future challenges. Ther Deliv. 2014;5(7):843–857.
- Chen B, Wei J, Iliescu C. Sonophoretic enhanced microneedles array (SEMA)-improving the efficiency of transdermal drug delivery. Sens Actuators, B Chem. 2010;145(1):54–60.
- Han T, Das DB. Permeability enhancement for transdermal delivery of large molecules using low-frequency sonophoresis combined with microneedles. J Pharm Sci. 2013;102(10):3614–3622.
- Hui S-W, Wong T-W, Ko S-F. Enhancing transdermal drug delivery with electroporation. Recent Pat Drug Deliv Formul. 2008;2(1):51–57.
- Choi SO, Kim YC, Park JH, et al. An electrically active microneedle array for electroporation. Biomed Microdevices. 2010;12(2):263–273.
- Yan K, Todo H, Sugibayashi K. Transdermal drug delivery by in-skin electroporation using a microneedle array. Int J Pharm. 2010;397(1–2):77–83.
- Lee H, Song C, Baik S, et al. Device-assisted transdermal drug delivery. Adv Drug Deliv Rev. 2018;127:35–45.
- Vaidya J, Shende P. Potential of sonophoresis as a skin penetration technique in the treatment of rheumatoid arthritis with transdermal patch. AAPS PharmSciTech. 2020;21(5):1–9.
- Kumar V, Banga AK. Modulated iontophoretic delivery of small and large molecules through microchannels. Int J Pharm. 2012;434(1–2):106–114.
- Wu XM, Todo H, Sugibayashi K. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J Control Release. 2007;118(2):189–195.
- Seah BCQ, Teo BM. Recent advances in ultrasound-based transdermal drug delivery. Int J Nanomedicine. 2018;13:7749–7763.
- Smith NB. Perspectives on transdermal ultrasound-mediated drug delivery. Int J Nanomedicine. 2007;2(4):585–594.
- Pamornpathomkul B, Duangjit S, Laohapatarapant S, et al. Transdermal delivery of fluorescein isothiocyanate-dextrans using the combination of microneedles and low-frequency sonophoresis. Asian J Pharm Sci. 2015;10(5):415–424.
- Hooper JW, Golden JW, Ferro AM, et al. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine. 2007;25(10):1814–1823.
- Petchsangsai M, Rojanarata T, Opanasopit P, et al. The combination of microneedles with electroporation and sonophoresis to enhance hydrophilic macromolecule skin penetration. Biol Pharm Bull. 2014;37(8):1373–1382.
- Piñón-Segundo E, Nava-Arzaluz MG, Ganem-Rondero A. Effect of the use of chemical enhancers combined with sonophoresis, electroporation, or microneedles on transdermal drug delivery. In: Percutaneous Penetration Enhance Phys Methods Penetration Enhance. 2017:399–419.
- Pathan IB, Setty CM. Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res. 2009;8:173–179.
- Yang Y, Kalluri H, Banga AK. Effects of chemical and physical enhancement techniques on transdermal delivery of cyanocobalamin (vitamin B12) in vitro. Pharmaceutics. 2011;3(3):474–484.
- Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56(5):603–618.
- Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci. 2009;36(4–5):511–523.
- Vitorino C, Almeida A, Sousa J, et al. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Eur J Pharm Biopharm. 2014;86(2):133–144.
- Kim KH, Kim Y-S, Lee S, et al. Transdermal delivery systems in cosmetics. Biomed Dermatol. 2020;4(1):1–12.
- Patel D, Kumar P, Thakkar HP. Lopinavir metered-dose transdermal spray through microporated skin: permeation enhancement to achieve therapeutic needs. J Drug Deliv Sci Technol. 2015;29:173–180.
- Mojeiko G, de Brito M, Salata GC, et al. Combination of microneedles and microemulsions to increase celecoxib topical delivery for potential application in chemoprevention of breast cancer. Int J Pharm. 2019;560:365–376.
- Zhang P, Zhang Y, Liu CG. Polymeric nanoparticles based on carboxymethyl chitosan in combination with painless microneedle therapy systems for enhancing transdermal insulin delivery. RSC Adv. 2020;10(41):24319–24329.
- Li QY, Zhang JN, Chen BZ, et al. A solid polymer microneedle patch pretreatment enhances the permeation of drug molecules into the skin. RSC Adv. 2017;7(25):15408–15415.
- Shende P, Salunke M. Transepidermal microneedles for co-administration of folic acid with methotrexate in the treatment of rheumatoid arthritis. Biomed Phys Eng Express. 2019;5(2):025023.
- Qiu Y, Gao Y, Hu K, et al. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release. 2008;129(2):144–150.
- Kelchen MN, Brogden NK. In vitro skin retention and drug permeation through intact and microneedle pretreated skin after application of propranolol loaded microemulsions. Pharm Res. 2018;35(12):1–12.
- Vora LK, Vavia PR, Larrañeta E, et al. Novel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug. J Interdiscip Nanomedicine. 2018;3(2):89–101.
- Kar M, Chourasiya Y, Maheshwari R, et al. Current developments in excipient science: implication of quantitative selection of each excipient in product development. In Basic fundamentals of drug delivery. London: Academic Press; 2018.
- Iqbal B, Ali J, Baboota S. Recent advances and development in epidermal and dermal drug deposition enhancement technology. Int J Dermatol. 2018;57(6):646–660.
- Donnelly RF, Garland MJ, Alkilani AZ. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery. Methods Mol Biol. 2014;1141:121–132.
- Sardesai M, Shende P. Engineering of nanospheres dispersed microneedle system for antihypertensive action. CDD. 2020;17(9):776–786.